Similar articles for PMID: 35197273

Year	Number of Results
2007	1
2010	2
2011	2
2013	6
2014	7
2015	9
2016	13
2017	12
2018	9
2019	14
2020	10
2021	20
2022	11

1

False positive ⁶⁸Ga-DOTATATE PET-CT in Hereditary hypophosphatemic-osteomalacia mimicking culprit lesions of tumor induced osteomalacia.

Parghane RV, Basu S. Parghane RV, et al. J Nucl Med Technol. 2022 Feb 23:jnmt.121.263776. doi: 10.2967/jnmt.121.263776. Online ahead of print. J Nucl Med Technol. 2022. PMID: 35197273

2

Comparison of ¹⁸ F-FDG PET/CT and ⁶⁸ Ga-DOTATATE PET/CT in the Targeted Imaging of Culprit Tumors Causing Osteomalacia.

Yu HN, Liu L, Chen QS, He Q, Li YS, Wang Y, Gao S. Yu HN, et al. Orthop Surg. 2021 May;13(3):791-798. doi: 10.1111/os.12980. Epub 2021 Mar 11. Orthop Surg. 2021. PMID: 33709632 Free PMC article.

3

68Ga DOTATATE PET/CT is an Accurate Imaging Modality in the Detection of Culprit Tumors Causing Osteomalacia.

Zhang J, Zhu Z, Zhong D, Dang Y, Xing H, Du Y, Jing H, Qiao Z, Xing X, Zhuang H, Li F. Zhang J, et al. Clin Nucl Med. 2015 Aug;40(8):642-6. doi: 10.1097/RLU.0000000000000854. Clin Nucl Med. 2015. PMID: 26053726

4

Comparison of 18F-FDG and 68Ga DOTATATE PET/CT in localization of tumor causing oncogenic osteomalacia.

Agrawal K, Bhadada S, Mittal BR, Shukla J, Sood A, Bhattacharya A, Bhansali A. Agrawal K, et al. Clin Nucl Med. 2015 Jan;40(1):e6-e10. doi: 10.1097/RLU.0000000000000460. Clin Nucl Med. 2015. PMID: 24999675

5

Increased Activity Due to Fractures Does Not Significantly Affect the Accuracy of 68Ga-DOTATATE PET/CT in the Detection of Culprit Tumor in the Evaluation of Tumor-Induced Osteomalacia.

Ding J, Hu G, Wang L, Li F, Huo L. Ding J, et al. Clin Nucl Med. 2018 Dec;43(12):880-886. doi: 10.1097/RLU.0000000000002290. Clin Nucl Med. 2018. PMID: 30273206

6

68Ga DOTA-TATE PET/CT allows tumor localization in patients with tumor-induced osteomalacia but negative 111In-octreotide SPECT/CT.

Breer S, Brunkhorst T, Beil FT, Peldschus K, Heiland M, Klutmann S, Barvencik F, Zustin J, Gratz KF, Amling M. Breer S, et al. Bone. 2014 Jul;64:222-7. doi: 10.1016/j.bone.2014.04.016. Epub 2014 Apr 24. Bone. 2014. PMID: 24769333

7

Utility of 18F-AlF-NOTA-Octreotide PET/CT in the Localization of Tumor-Induced Osteomalacia.

Long T, Hou J, Yang N, Zhou M, Li Y, Li J, Tang Y, Chen D, Hu S. Long T, et al. J Clin Endocrinol Metab. 2021 Sep 27;106(10):e4202-e4209. doi: 10.1210/clinem/dgab258. J Clin Endocrinol Metab. 2021. PMID: 33864458

8

Usefulness of ⁶⁸Ga-DOTATOC PET/CT to localize the culprit tumor inducing osteomalacia.

Lee DY, Lee SH, Kim BJ, Kim W, Yoon PW, Lee SJ, Oh SJ, Koh JM, Ryu JS. Lee DY, et al. Sci Rep. 2021 Jan 19;11(1):1819. doi: 10.1038/s41598-021-81491-2. Sci Rep. 2021. PMID: 33469091 Free PMC article.

9

Oncogenic osteomalacia: role of Ga-68 DOTANOC PET/CT scan in identifying the culprit lesion and its management.

Singh D, Chopra A, Ravina M, Kongara S, Bhatia E, Kumar N, Gupta S, Yadav S, Dabadghao P, Yadav R, Dube V, Kumar U, Dixit M, Gambhir S. Singh D, et al. Br J Radiol. 2017 Apr;90(1072):20160811. doi: 10.1259/bjr.20160811. Epub 2017 Feb 9. Br J Radiol. 2017. PMID: 28181822 Free PMC article.

10

Diagnostic performance and impact on patient management of ⁶⁸Ga-DOTA-TOC PET/CT for detecting osteomalacia-associated tumours.

Paquet M, Gauthé M, Zhang Yin J, Nataf V, Bélissant O, Orcel P, Roux C, Talbot JN, Montravers F. Paquet M, et al. Eur J Nucl Med Mol Imaging. 2018 Sep;45(10):1710-1720. doi: 10.1007/s00259-018-3971-x. Epub 2018 Mar 12. Eur J Nucl Med Mol Imaging. 2018. PMID: 29532101

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed